Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 14, 2019

View Archived Issues

Macrophage-glioma cell interactions can be targeted for PTEN-null glioma

Potential of targeting the miR-21/Wnt/CD44v6 pathway in ovarian cancer

Pharmacological stabilization of TYK2 kinase could treat multiple immune-mediated diseases

Fecal transplants for pancreatic cancer?

High-throughput method for discovering gene interactions

IFN punctures BBB

A neutralizing H7N9 Ab isolated from an infected patient kills infected cells and confers protection

CEPI and PHV enter partnering agreement for development of rVSV-Nipah vaccine candidate

Shanghai Institute of Materia Medica and Suzhou Suplead Life Sciences patent BRD4 inhibitors

New beta-secretase inhibitors synthesized at Novartis

Medshine Discovery presents new antibacterials

New mGluR5 allosteric modulators discovered at Recordati Industria Chimica e Farmaceutica

Kezar Life Sciences initiates PRESIDIO and MARINA phase II studies of KZR-616

DS-39201083 is a new derivative of conolidine with superior analgesic activity

SHR-1653 as a novel highly potent and selective OTR antagonist

Pharmadiall presents new coagulation factor Xa inhibitors

AC Immune partners with University of Pennsylvania to further study TDP-43

CureVac, Yale to jointly discover mRNA-based candidates for pulmonary diseases

DelMar reports updated results from phase II study of VAL-083 in newly diagnosed GBM

Enrollment ongoing in phase III study of tucatinib plus T-DM1 in HER2+ breast cancer

European Commission approves ibrutinib for expanded use in two indications

Too much oxygen may be issue in Leigh syndrome

FDA clears Heat Biologics' IND for study of HS-130 plus HS-110

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...